home / stock / cvrx / cvrx news


CVRX News and Press, CVRx Inc. From 01/14/26

Stock Information

Company Name: CVRx Inc.
Stock Symbol: CVRX
Market: NASDAQ
Website: cvrx.com

Menu

CVRX CVRX Quote CVRX Short CVRX News CVRX Articles CVRX Message Board
Get CVRX Alerts

News, Short Squeeze, Breakout and More Instantly...

CVRX - CVRx, Inc. (CVRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2026-01-14 21:15:57 ET CVRx, Inc. (CVRX) 44th Annual J.P. Morgan Healthcare Conference January 14, 2026 6:45 PM EST... Read the full article on Seeking Alpha For further details see: CVRx, Inc. (CVRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

CVRX - CVRx reports preliminary 2025 results, issues 2026 guidance

2026-01-12 09:39:37 ET More on CVRx CVRx, Inc. (CVRX) Q3 2025 Earnings Call Transcript CVRx anticipates mid-teens growth in 2026 as sales force productivity and reimbursement improvements build momentum Seeking Alpha’s Quant Rating on CVRx Historical e...

CVRX - CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2025 Financial Results and Issues Fiscal 2026 Guidance

Fourth quarter revenue expected to be $15.9 million to $16.1 million, representing growth of 4% to 5% Full year revenue expected to be $56.5 million to $56.7 million, representing growth of 10% to 11% Fiscal 2026 revenue expected to be between $63 million and $67 million, representing growt...

CVRX - CVRx Announces Implementation of New Category I CPT Codes for Barostim Therapy

MINNEAPOLIS, Jan. 06, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, confirmed today that ...

CVRX - CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference

MINNEAPOLIS, Dec. 22, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that the management...

CVRX - CVRx to Participate at the Piper Sandler 37th Annual Healthcare Conference

MINNEAPOLIS, Nov. 19, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that the management...

CVRX - Overweight Recommendation Issued On CVRX By Cantor Fitzgerald

2025-11-06 09:15:17 ET Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for CVRX on November 6, 2025 01:45PM ET. The previous analyst recommendation was Overweight. CVRX was trading at $9.835 at issue of the analyst recommendation. The overall analyst consensus...

CVRX - CVRx anticipates mid-teens growth in 2026 as sales force productivity and reimbursement improvements build momentum

2025-11-05 22:52:10 ET More on CVRx CVRx, Inc. (CVRX) Q3 2025 Earnings Call Transcript Seeking Alpha’s Quant Rating on CVRx Historical earnings data for CVRx Financial information for CVRx Read the full article on Seeking Alpha For furt...

CVRX - CVRx, Inc. (CVRX) Q3 2025 Earnings Call Transcript

2025-11-05 22:51:25 ET CVRx, Inc. (CVRX) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Kevin Hykes - President, CEO & Director Jared Oasheim - Chief Financial Officer Conference Call Participants Mike Vallie - Westwicke Par...

CVRX - CVRx GAAP EPS of -$0.49 beats by $0.01, revenue of $14.7M beats by $0.54M

2025-11-05 17:00:45 ET More on CVRx Seeking Alpha’s Quant Rating on CVRx Historical earnings data for CVRx Financial information for CVRx Read the full article on Seeking Alpha For further details see: CVRx GAAP EPS of -$0.49 beats by $0.01...

Previous 10 Next 10